Oric Pharmaceuticals, Inc.

ORIC · Nasdaq · SIC 2834: Pharmaceutical Preparations
99
SEC Filings

Business Summary

PART I Item 1. Bu siness. Overview ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to improving patients lives by O vercoming R esistance I n C ancer . Profound advancements in oncology drug development have expanded the treatment options available to patients, yet therapeutic resistance and relapse continue to limit the efficacy and duration of clinical benefit of such treatments. Collectively, our founders and management team have a decades-long heritage of identif...

Next Earnings

Q2 FY2026 — expected 2026-08-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionORICdiscussed_in_filing Cybersecurity
topic_mentionORICdiscussed_in_filing Cybersecurity
topic_mentionORICdiscussed_in_filing Healthcare & Bio
topic_mentionORICdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-232025-12-310001193125-26-064005EDGAR99K words
2025-02-182024-12-310000950170-25-022273EDGAR—
2024-03-112023-12-310000950170-24-029298EDGAR—
2023-03-162022-12-310000950170-23-008483EDGAR—
2022-03-212021-12-310000950170-22-004239EDGAR—
2021-03-232020-12-310001564590-21-014865EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001193125-25-280234EDGAR66K words
2025-08-122025-06-300000950170-25-107359EDGAR—
2025-05-052025-03-310000950170-25-063564EDGAR—
2024-11-122024-09-300000950170-24-125471EDGAR—
2024-08-122024-06-300000950170-24-095467EDGAR—
2024-05-062024-03-310000950170-24-053582EDGAR—
2023-11-062023-09-300000950170-23-059415EDGAR—
2023-08-102023-06-300000950170-23-041362EDGAR—
2023-05-082023-03-310000950170-23-018839EDGAR—
2022-11-072022-09-300000950170-22-022631EDGAR—
2022-08-112022-06-300000950170-22-016894EDGAR—
2022-05-092022-03-310000950170-22-008512EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001193125-26-134618EDGAR7K words
2026-02-230001193125-26-064291EDGAR—
2026-02-230001193125-26-063974EDGAR—
2025-12-080001193125-25-310472EDGAR—
2025-11-130001193125-25-280247EDGAR—
2025-11-130001193125-25-280196EDGAR—
2025-08-120000950170-25-107313EDGAR—
2025-06-130001193125-25-140725EDGAR—
2025-05-280001193125-25-129531EDGAR—
2025-05-050000950170-25-063540EDGAR—

99 total filings indexed. 71 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001796280
TickerORIC
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: a49b2aaa960a70de74a88b042e05c7584c6eb760006b4ebdb55eda79e02911df
parent: 38d469fb0c226990edd1ca2c28565fc5d389278e1d005fa4e026c2b9690378fe
content hash: ce3c02c15dc913cd730a13a54b856a7cf7fee1c55c006ffc00b426f051a73e88
signed: 2026-04-13T04:46:45.345Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf